AnaptysBio
Price & Volume
Stats
See moreOpen | $31.91 |
Previous Close | $31.97 |
Day Range | $30.13-$32.14 |
52W Range | $12.21-$36.54 |
Market Cap | $856.5M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $123.1M |
Revenue Growth (YoY) | 102.9% |
Gross Profit (12 Mos) | -$40.6M |
Diluted EPS | -$5.70 |
News
See moreYahoo Finance • 2 days ago
Biggest stock movers today: UUUU, FLY, and more
Yahoo Finance • 3 days ago
AnaptysBio splits operations into two companies
Yahoo Finance • 3 days ago
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
Yahoo Finance • 3 days ago
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
About
CEO | Mr. Daniel R. Faga |
Address | 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 136 |
